Effervescent Cold Relief Tablet, Effervescent
NDC Package 53943-873-20

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Effervescent Cold Relief (aspirin, chlorpheniramine maleate, phenylephrine bitartrate) tablets is ■ do not use more than directed (see overdose warning)■ adults and children 12 years and over: take 2 tablets fully dissolved in 4 ounces of water every 4-6 hours■ do not take more than 8 tablets in 24 hours.■ children under 12 years: ask a doctor. This formulation utilizes a tablet, effervescent delivery system. Marketed by Discount Drug Mart, this product is identified by NDC 53943-873 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
53943-873-20
Package Description
20 POUCH in 1 CARTON / 2 TABLET, EFFERVESCENT in 1 POUCH
Product Code
11-Digit Billing Format
53943087320
RxNorm Crosswalk
  • RxCUI: 1536840 - aspirin 325 MG / chlorpheniramine maleate 2 MG / phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet
  • RxCUI: 1536840 - ASA 325 MG / Chlorpheniramine Maleate 2 MG / Phenylephrine bitartrate 7.8 MG Effervescent Oral Tablet

Clinical Specifications

Proprietary Name
Effervescent Cold Relief
Non-Proprietary Name
Aspirin, Chlorpheniramine Maleate, Phenylephrine Bitartrate
Substance Name
Aspirin; Chlorpheniramine Maleate; Phenylephrine Bitartrate
Dosage Form
Tablet, Effervescent - A solid dosage form containing mixtures of acids (e.g., citric acid, tartaric acid) and sodium bicarbonate, which release carbon dioxide when dissolved in water; it is intended to be dissolved or dispersed in water before administration.
Administration Route
Oral - Administration to or by way of the mouth.
Usage Information
■ do not use more than directed (see overdose warning)■ adults and children 12 years and over: take 2 tablets fully dissolved in 4 ounces of water every 4-6 hours■ do not take more than 8 tablets in 24 hours.■ children under 12 years: ask a doctor

Regulatory & Marketing

Labeler Name
Discount Drug Mart
Product Type
Human Otc Drug
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
01-30-2015
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53943-873-20 identifies a specific commercial package of 20 pouch in 1 carton / 2 tablet, effervescent in 1 pouch of Effervescent Cold Relief, a human over the counter drug labeled by Discount Drug Mart. This tablet, effervescent is formulated for oral use and contains aspirin; chlorpheniramine maleate; phenylephrine bitartrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Discount Drug Mart on January 30, 2015. The current certification is valid through December 31, 2026.

How is this Discount Drug Mart product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53943087320. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
53943-873-20
11-Digit CMS (5-4-2)
53943-0873-20

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.